Accreditation
Event format
Language
The official language of the symposium will be English. Simultaneous translation from English to Spanish will be provided.
We offer our registered users tailored information, free online courses and exclusive content.
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?The official language of the symposium will be English. Simultaneous translation from English to Spanish will be provided.
Federica Russetti
c/o Meridiano Congress International
T +39 06 88 595 250 - F +39 06 88595 234
federica.russetti@meridiano.it
This fee includes:
EXCEMED is involved in a comprehensive educational programme to increase knowledge in cardiovascular diseases, diabetes and thyroid disorder, and is proud to organize the 2015 Latin American conference on cardiometabolic diseases management. This meeting will address the most recent advancements of research in these areas of cardiometabolic medicine and, in particular, will discuss the best approaches for clinical management of the complexity of cardiometabolic patients in daily practice.
Cardiovascular diseases, diabetes and thyroid disorders represent the most common pathologies in daily clinical practice and often coexist in the same patient. Diabetes Mellitus, especially type 2, is a growing epidemic in Central and South America as 8.1% of the population (25 million people) in South and Central America has diabetes (6th IDF Atlas). Diabetes management is a big challenge considering the complexity of diabetes pathophysiology and the high healthcare expenditure associated managing diabetes and its complications. Thyroid disorders also impact cardiometabolic health and are prevalent in Latin America, mostly due to iodine deficiency combined with genetic factors. High blood pressure is one of the leading causes of death in the world (Global Burden of Disease study - Lancet 2012) and heart failure is one of the leading causes of hospitalization worldwide with unacceptably high post-discharge mortality and re-hospitalization rates. The prevalence of patients with concomitant heart failure and metabolic disorders, particularly diabetes mellitus and thyroid diseases, continues to increase. Moreover, heart failure patients with concomitant endocrine disorders are a different pathophysiologic population, as peculiar metabolic and neurohormonal abnormalities always coexist in patients with endocrine diseases. Indeed, patients with heart failure and concomitant diabetes have a worse prognosis with increased rates of cardiovascular mortality and post- discharge hospitalization. Taken together, hypertension, heart failure, diabetes and thyroid disorders share common pathophysiologic mechanisms and clinical issues that are often tough tasks to face in clinical practice. EXCEMED is involved in a comprehensive educational programme to increase knowledge in cardiovascular diseases, diabetes and thyroid disorder, and is proud to organize the 2015 Latin American conference on cardiometabolic diseases management. This meeting will address the most recent advancements of research in these areas of cardiometabolic medicine and, in particular, will discuss the best approaches for clinical management of the complexity of cardiometabolic patients in daily practice.
By attending this live educational symposium, participants will be able to:
Understand the pathophysiology linking heart failure, hypertension, diabetes and thyroid disorders
Use the correct diagnostic and therapeutic strategies to face difficult cases in clinical practice
Consciously apply the most recent guidelines to the management of diabetes and thyroid diseases
Manage the complexity of cardiometabolic patients
An application will be made to the EACCME® for CME accreditation.
This programme is endorsed by Latin American Thyroid Society (LATS)
08.00 Registration
09.00 Welcome and Introduction
09.15 L1 Heart rate control in heart failure: old and new drugs, E. Agabiti-Rosei, Italy
09.40 L2 New perspectives on heart failure: Speaker to be announced
10.05 L3 Renal sympathetic denervation therapy for resistant hypertension, A. Coca, Spain
10.30 Question and answer
10.45 Coffee break
11.05 L4 The nature of Type 2 Diabetes: relationships to arterial & cardiac function and heart failure, K. Cruickshank, UK
11.25 L5 Diabetes and heart rate control dysfunction (Cardiac autonomic Neuropathy), E. Maddaloni, USA
11.50 L6 Cardiometabolic implications of thyroid dysfunction, M. Khamaisi, USA
12.20 Question and answer
12.35 Lunch
14.00 L7 Pre-diabetes: relevance and treatment, N. Napoli, Italy
14.25 L8 Diabetes management: how to choose the right drug?, R. Castañeda, Mexico
14.50 L9 Diabetes in pregnancy, Speaker to be announced
15.15 Question and answer
15.30 Coffee Break
16.00 L10 Cardiovascular mortality in diabetes, H. Keenan, USA
16.25 L11 Cardiometabolic implications of antidiabetic drugs, Speaker to be announced
16.50 L12 Diabetic osteopathy and the bone-vascular axis, N. Napoli, Italy
17.15 Question and answer
17.30 Take home messages
Concluding remarks
09.00 L13 Thyroid nodules in clinical practice: from medical therapy to ultrasonically-guide intervention, Speaker to be announced
09.25 L14 Hypothyroidism and Hyperthyroidism in pregnancy, G. Brenta, Argentina
09.50 Question and answer
10.05 D1 Statins and diabetes: Pros, H. Keenan, USA
Statins and diabetes: Cons, E. Maddaloni, USA
10.45 D2 Subclinical hypothyroidism: to treat or not to treat? Pros, A. S. Caballero, Mexico
Subclinical hypothyroidism: to treat or not to treat? Cons, G. Brenta, Argentina
11.30 Coffee break
11.50 L16 Personalised therapy to manage the cardiometabolic patient, K. Cruickshank, UK
12.15 L17 Poly-pharmacotherapy: Compliance and Adherence, N. de La Garza, Mexico
12.40 Question and answer
12.55 Take home message
13.10 Closing remarks from the scientific organiser
13.15 End of the conference
Closing Lunch
Salita San Nicola da Tolentino, 1/B 00187 - Rome, Italy
Programme Manager: Giovanna Rossi
Medical Advisor: Ernesto Maddaloni
Enrico Agabiti-Rosei
University of Brescia
Brescia, Italy
Gabriela Brenta
Cesar Milstein Hospital
Buenos Aires, Argentina
Alejandro Sosa Caballero
Tlacotalpan
Cuauhtémoc Distrito Federal DF
Mexico City, Mexico
Rutila Castañeda
Clinical Epidemiology
Research Unit
Hospital General Regional
No 1 Dr Carlos Mac Gregor
Sánchez Navarro
Mexico City, D.F., Mexico
Antonio Coca
Internal Medicine
Hypertension & Vascular Risk
Unit Hospital Clinic
University of Barcelona
Barcelona, Spain
Natalia De la Garza
Universidad Autónoma de Nuevo León
Hospital San José
Centro Médico San Francisco
Monterrey, Nuevo León, Mexico
Hillary Keenan
Joslin Diabetes Center
Boston, MA, USA
Mogher Khamaisi
Rambam Medical Center
Harvard Medical School
Joslin Diabetes Center
Boston, MA, USA
Kennedy Kruickshank
Diabetes & Nutritional Sciences Division
King's College London
London, UK
Ernesto Maddaloni
University Campus Bio-Medico
Rome, Italy
Joslin Diabetes Center
(Harvard Medical School)
Boston, MA, USA
Nicola Napoli
University Campus Bio-Medico of Rome (UCBM)
Rome, Italy
Via Mentana, 2B 00185 Rome, Italy
Congress Coordinator: David H. Slangen
Tel: +39 0688595 209
Fax: +39 0688535 234
david.slangen@meridiano.it